Health
newsGP – ‘Important’ study shows gout medication can halt coronary disease progression – RACGP
The major clinical trial found use of low dose colchicine reduces heart attacks and the need for coronary stenting or bypass surgery by 30%.
News
The major clinical trial found use of low dose colchicine reduces heart attacks and the need for coronary stenting or bypass surgery by 30%.
Coronary heart disease is the leading cause of death in Australia.
The international study, published in The New England Journal of Medicine, examined the effect of low dose colchicine in patients with chronic coronary disease who were already taking established treatments.The two-year randomised, controlled, double-blind trial, led by GenesisCare i…
-
Noosa News16 hours agoWhat the numbers really say about Crisafulli’s crime crackdown
-
General16 hours agoThe US dollar’s demise has consequences for Australia
-
Noosa News13 hours agoTwo bodies found in search for missing Brisbane couple in Tasmania
-
Noosa News8 hours agoForty years inside a Brisbane second-hand store